A Suspected Case of Fabuloso® Associated Pseudomonas Cellulitis

Teren Yedikian^1, , Lisa Piñero¹, Erica Rego¹, Radhika Malhotra¹, Juan Bello¹ and Ravi Upadhyay¹

¹Department of Medicine, Rutgers New Jersey Medical School, Newark, NJ, USA

Cite this paper

Teren Yedikian, Lisa Piñero, Erica Rego, Radhika Malhotra, Juan Bello and Ravi Upadhyay. A Suspected Case of Fabuloso® Associated Pseudomonas Cellulitis. American Journal of Medical Case Reports. 2023; 11(5):101-103. doi: 10.12691/AJMCR-11-5-5

Abstract

Pseudomonas aeruginosa and Pseudomonas fluorescens are gram-negative bacilli that are ubiquitous in the environment and are known to cause folliculitis, pneumonia, and otitis externa typically in immunocompromised patients. Pseudomonas spp. are rarely associated with cellulitis. We present a case of a 47-year-old woman who presented to the emergency room with left lower leg edema and erythema after being exposed to the multi-purpose cleaning product, Fabuloso®. Recently, a recall regarding multiple lots of this cleaner was made as some of the products have been found to grow both Pseudomonas aeruginosa and Pseudomonas fluorescens. Physical exam revealed a warm, erythematous, and lower left leg lesion that was tender to touch. A computerized tomography of the lower left leg indicated a soft tissue infection with no abscesses or collections. Antibiotics were administered to cover against bacterial causes of nonpurulent cellulitis. The lesion continued to spread, and only began to decrease in size when antimicrobial coverage was broadened to target Pseudomonas spp. This case demonstrates the importance of detailed history taking including environmental exposures as well as rapid recognition of antimicrobial failure.

Keywords

cellulitis, Pseudomonas aeruginosa, Pseudomonas fluorescens, Fabuloso®

Copyright

This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References

[1]	Wilson MG, Pandey S. Pseudomonas Aeruginosa. StatPearls. Treasure Island (FL) 2023.
[2]	Spernovasilis N, Psichogiou M, Poulakou G. Skin manifestations of Pseudomonas aeruginosa infections. Curr Opin Infect Dis. 2021; 34(2): 72-9.
[3]	Nishimura T, Hattori K, Inoue A, Ishii T, Yumoto T, Tsukahara K, et al. Bacteremia or pseudobacteremia? Review of pseudomonas fluorescens infections. World J Emerg Med. 2017; 8(2): 151-4.
[4]	Rrapi R, Chand S, Kroshinsky D. Cellulitis: A Review of Pathogenesis, Diagnosis, and Management. Med Clin North Am. 2021; 105(4): 723-35.
[5]	“Voluntary Recall of Select Fabuloso® Products Made in the United States”, Fabuloso®, https://www.fabuloso.com/recall (accessed Mar. 26, 2023).
[6]	Mergenhagen KA, Starr KE, Wattengel BA, Lesse AJ, Sumon Z, Sellick JA. Determining the Utility of Methicillin-Resistant Staphylococcus aureus Nares Screening in Antimicrobial Stewardship. Clin Infect Dis. 2020; 71(5): 1142-8.
[7]	Wahab AA, Rahman MM. Pseudomonas aeruginosa bacteremia secondary to acute right leg cellulitis: case of communi-ty-acquired infection. EXCLI J. 2013; 12: 997-1000.
[8]	Singh P, Montano A, Bostick A. Rapid severe sepsis from Pseudomonas fluorescens/putida bacteremia due to skin and soft tissue infection - A case report. Ann Med Surg (Lond). 2021; 70: 102845.
[9]	Silverio MP, Kraychete GB, Rosado AS, Bonelli RR. Pseudomonas fluorescens Complex and Its Intrinsic, Adaptive, and Acquired Antimicrobial Resistance Mechanisms in Pristine and Human-Impacted Sites. Antibiotics (Basel). 2022; 11(8).